Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00057551 · ClinicalTrials.gov registry record · Phase 4
Research Evaluating the Value of Augmenting Medication With Psychotherapy
A Phase 4 study, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- Phase 4
- Development phase
- 491
- Enrollment target
NCT00057551: Completed Phase 4 study, sponsored by Weill Medical College of Cornell University.
NCT00057551 is a Phase 4 study that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 491 participants, roughly in line with the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00057551, a Phase 4 study, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 491 participants
- Enrollment target
Study Summary
This 24-week study, with a 12-month follow up period, will compare the effectiveness of antidepressant medication alone to the combination of psychotherapy and antidepressant medication in patients with chronic depression.
Primary Outcome
Hamilton Depression Scale (HAM-D)\<8 and does not meet DSM-IV criteria for Major Depressive Disorder for 2 consecutive visits
Interventions
- BEHAVIORAL CBASP
- BEHAVIORAL Brief Supportive Psychotherapy
- DRUG Medication Only
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 491 participants |
| Start Date | 2003-04 |
| Est. Completion | 2007-03 |
| Phase | Phase 4 |
What the finished NCT00057551 record still lists
NCT00057551 is an interventional study that assigns participants to a tested intervention. The registered 491 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target.
The record links to 0 conditions, and to 3 interventions - of which CBASP is the first listed.
NCT00057551 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00057551 about?
NCT00057551 is a clinical study titled "Research Evaluating the Value of Augmenting Medication With Psychotherapy". This 24-week study, with a 12-month follow up period, will compare the effectiveness of antidepressant medication alone to the combination of psychotherapy and antidepressant medication in patients with chronic depression.
What is the current status of trial NCT00057551?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 491 participants. The study started on 2003-04. Estimated completion is 2007-03.
What interventions are being tested in trial NCT00057551?
The interventions under investigation include: CBASP (BEHAVIORAL), Brief Supportive Psychotherapy (BEHAVIORAL), Medication Only (DRUG).
Who is sponsoring clinical trial NCT00057551?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00057551's enrollment target sits among peer trials
491 179th of 2000 higher than 1,822 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03418961 · 491 participants · Phase 3
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
- NCT05861973 · 492 participants · NA
SMARTer Weight Loss Management
- NCT05908331 · 492 participants · NA
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
- NCT06152575 · 492 participants · Phase 3
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia